Is Pfizer Stock a Bargain for Long-Term Investors?

Wall Street's bearish take on this proven innovator may not be warranted. The Federal Reserve's ongoing rate-cutting cycle is already triggering a major shift in investor sentiment. As yields on fixed-income investments decline, institutional investors are clearly rotating into dividend-paying stocks, particularly those trading at reasonable valuations and above-average yields. In fact, several high-yield dividend stocks have outperformed the S&P 500 in 2024. This environment makes Pfizer's (PFE -0.74%) hef ...